Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature

Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature

Purpose: Trans-arterial radioembolization is a well-studied tumoricidal treatment for liver malignancies; however, consensus and evidence regarding periprocedural prophylactic medication (PPM) are lacking. Methods: A single-center retrospective analysis from 2014 to 2020 was performed in patients tr...

Full description

Bibliographic Details
Main Authors: Manon N. G. J. A. Braat, Sander C. Ebbers, Ahmed A. Alsultan, Atal O. Neek, Rutger C. G. Bruijnen, Maarten L. J. Smits, Joep de Bruijne, Marnix G. E. H. Lam, Arthur J. A. T. Braat
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Diagnostics
Subjects:
radioembolization
hepatotoxicity
drug-induced liver disease
prophylaxis
Online Access:https://www.mdpi.com/2075-4418/13/24/3652

Internet

https://www.mdpi.com/2075-4418/13/24/3652

Similar Items